Capstone Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $427K | Sell |
|
|||||
|
2025
Q2 | $578K | Buy |
|
|||||
|
2025
Q1 | $349K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $780K | Buy |
|
|||||
|
2023
Q4 | $315K | Sell |
|
|||||
|
2023
Q3 | $377K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $501K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $312K | Sell |
|
|||||
|
2017
Q1 | $662K | Buy |
|